Effects of some human pharmaceuticals on freshwater organisms;Impact de médicaments à usage humain sur les organismes aquatiques d'eau douce

Environnement, Risques et Sante

Volumn 5, Issue 4, 2006, Pages 290-295

  Garric, Jeanne ^a   Ferrari, Benoît ^b   Fraysse, Benoît ^a   Mons, Raphaël ^a   Vollat, Bernard ^a  

^a CEMAGREF   (France)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Fishes; Fresh water; Invertebrates; Pharmaceutical preparation; Toxic actions; Toxicity tests

Indexed keywords

ACEBUTOLOL; AMOXICILLIN; BROMAZEPAM; CARBAMAZEPINE; DICLOFENAC; FENOFIBRATE; FLUOXETINE; IBUPROFEN; PAROXETINE; PROPRANOLOL; SULFAMETHOXAZOLE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; CALCULATION; CHRONIC TOXICITY; CLADOCERA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; EMBRYO; EMBRYO DEVELOPMENT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MANAGEMENT; FRANCE; FRESHWATER ENVIRONMENT; IC 50; LETHALITY; NONHUMAN; RISK ASSESSMENT; ROTIFERA; WATER POLLUTION; ZEBRA FISH;

BRACHIONUS CALYCIFLORUS; CERIODAPHNIA DUBIA; CLADOCERA; DANIO RERIO; INVERTEBRATA;

EID: 33747399448     PISSN: 16350421     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Christensen FM. Pharmaceuticals in the environment-A human risk? Reg Toxicol Pharmacol 1998; 28: 212-21.
2. Schulman LJ, Sargent EV, Naumann BD, Faria EC, Dolan DG, Wargo JP. A Human Health Risk Assessment of Pharmaceuticals in the Aquatic Environment. Hum Ecol Risk Assess 2002; 8: 657-80.
3. Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect 1999; 107(Supplement 6): 907-38.
4. Halling-Sorensen B, Nielsen SN, Lanzky PF, Ingerslev F, Holten Lützhoft HC, Jorgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment - A review. Chemosphere 1998; 36: 357-93.
5. Ternes TA. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998; 3: 3245-60.
6. Zuccato E, Calamari D, Natangelo M, Fanelli R. Presence of therapeutic drugs in the environment. Lancet 2000; 355: 1789-90.
7. Jones OAH, Voulvoulis N, Lester JN. Human pharmaceuticals in the aquatic environment: a review. Environ Technol 2001; 22: 1383-94.
8. Sacher F, Lange FT, Brauch HJ, Blankenhorn I. Pharmaceutical in groundwaters: Analytical methods and results of a monitoring program in Baden-Württemberg, Germany. J Chromatogr A 2001; 938: 199-210.
9. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 2002; 131: 5-17.
10. Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceutical, hormones, and other organic wastewater contaminants in U.S. Streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002; 36: 1202-11.
11. Purdom CE, Hardiman PA, Bye VJ, Eno NC, Tyler CR, Sumpter JP. Estrogenic effects of effluents from sewage treatment works. Chem Ecol 1994; 8: 275-85.
12. Jobling S, Sheahan D, Osborne J, Mathiessen P, Sumpter JP. Inhibition of testicular growth in rainbow trout (Onchorynchus mykiss) exposed to estrogenic alkylphenolic chemicals. Environ Toxicol Chem 1996; 15: 194-202.
13. Desbrow C, Routledge EJ, Brighty GC, Sumpter JP, Waldock M. Identification of estrogenic chemicals in STW effluent.1. Chemical fractionation and in vitro biological screening. Environ Sci Technol 1998; 32: 1549-58.
14. Tyler CR, Jobling S, Sumpter JP. Endocrine disruption in wildlife, a critical review of the evidence. Crit Rev Toxicol 1998;28:319-61.
15. Petrovic M, Solé M, Lopez de Alda MJ, Barcelo D. Endocrine disruptors in sewage treatment plants, receiving water and sediments, integration of chemical analysis and biological effects on feral carp. Environ Toxicol Chem 2002; 21: 2146-56.
16. European Agency for the Evaluation of Medicinal Products (EMEA)/Committee for proprietary medicinal products (CPMP). Note for guidance on environmental risk assessment on medicinal products for human use. Draft Report. CHMP/SWP/4447/00. London: EMEA/CPMP, 2005. http://www.emea.eu.int/pdfs/human/ swp/444700en.pdf.
17. Veterinary International Conference on Harmonisation (VICH). Environmental Impact Assessment (EIAs) for Veterinary Medicinal Products (VMPs) - Phase I. CVMP/VICH. CVMP/VICH/592/98-final. London: VICH, 2000. http://www.emea.eu.int/pdfs/vet/vich/059298en.pdf.
18. Veterinary International Conference on Harmonisation (VICH). Environmental Impact Assessment (EIAs) for Veterinary Medicinal Products (VMPs) - Phase II. CVMP/VICH. CVMP/VICH/790/03-final. London: VICH, 2004.
19. Webb SF. A data-based perspective on the environmental risk assessment of human pharmaceuticals I - Collation of available ecotoxicity data. In: Kümmerer K, ed. Pharmaceuticals in the environment - Sources, fate, effects and risks. Berlin: Springer-Verlag, 2001.
20. Ferrari B, Mons R, Vollat B, et al. Environmental risk assessment of 6 human pharmaceuticals: Are the current ERA procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 2004; 23: 1344-54.
21. Huggett DB, Brooks BW, Peterson B, Foran CM, Schlenk D. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms. Arch Environ Contam Toxicol 2002; 43: 229-35.
22. Garric J, Fraysse B, Vollat B, Mons R. Évaluation de l'écotoxicité de produits pharmaceutiques sur la survie, le développement et la reproduction de zooplancton et de poisson. Rapport final Enimed, Projet Pnetox n°04/2001. Lyon: Institut de recherche pour l'ingénierie de l'agriculture et de l'environnement (Cemagref), 2005.
23. Isnard P, Flammarion P, Roman G, et al. Statistical analysis of regulatory ecotoxicity tests. Chemosphere 2001; 45: 659-69.
24. Gulley DD, Boelter AN, Bergman HL. Toxstal/Datasys Statistical Software. Release 3.0. Laramie. Wyoming: Department of Zoology and Physiology, University of Wyoming, 1989.
25. Methods for measuring the acute toxicity of effluents and receiving waters to freshwater and marine organisms. EPA 600/4_90/027. Cincinnati (Ohio): Environmental Systems Laboratory, 1999.
26. Association française de normalisation (Afnor). Qualité de l'eau - Détermination de la toxicité chronique vis-à-vis de Brachionus calyciflorus en 48 heures - Essai d'inhibition de la croissance de la population. N°T90-377. Paris: Afnor, 2000.
27. Association française de normalisation (Afnor). Qualité de l'eau - Détermination de la toxicité chronique vis-à-vis de Ceriodaphnia dubia en 7 jours - Essai d'inhibition de la croissance de la population. N°T90-376. Paris: Afnor, 2000.
28. International Standard Organisation (ISO). Water Quality-Determination of Toxicity to Embryos and Larvae of Freshwater Fish - Semi-Static Method. N°12890. Geneva: ISO, 2000.
29. Radix P, Severin G, Schramm KW, Kettrup AAF. Reproduction disturbances of Brachionus calyciflorus (rotifer) for the screening of environmental endocrine disrupters. Chemosphere 2002; 47: 1097-101.
30. Tatarazako N, Oda S, Watanabe H, Morita M, Iguchi T. Juvenile hormone agonist affect the occurence of mâle daphnia. Chemosphere 2003; 53: 827-33.
31. Holten Lutzhoft HC, Halling-Sorensen B, Jorgensen SE. Algal toxicity of antibacterial agents applied in Danish fish farming. Arch Environ Contam Toxicol 1999; 36: 1-6.
32. Fraysse B, Mons R, Garric J. Development of a zebrafish 4-days embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicol Environ Saf 2006; 63: 253-67.
33. Langheinrich U. Zebrafish: A new model on the pharmaceutical catwalk. Bioassays 2003; 25: 904-12.
34. Huggett DB, Cook JC, Ericson JF, Williams RT. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum Ecol Risk Assess 2003; 9: 1789-99.
35. Ferrari B, Paxeus N, Lo Giudice R, Pollio A, Garric J. Ecotoxicological Impact of Pharmaceuticals Found in Treated Wastewater: Study of Carbamazepine, Clofibric acid and Diclofenac. Ecotoxicol Environ Sar 2003; 55: 359-70.
36. Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD. Toxic effects of the non-steroidal anti-inflammatory drug diclofénac. Part I: Histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 2004; 68: 141-50.
37. Triebskorn R, Casper H, Heyd A, Eikemper R, Kohler HR, Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofénac: Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 2004; 68: 151-66.
38. Cleuvers M. Aquatic Ecotoxicity of pharmaceutical including the assessment of combination effects. Toxicol Lett 2003; 142: 185-94.
39. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofénac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotox Environ Saf 2004; 59: 309-15.
40. Fraysse B, Garric J. Acute toxicity of isolated or combined β-blockers for Ceriodaphnia dubia Environ Toxicol Chem 2005; 24: 2470-6.